...
机译:基于NanoString的多基因检测作为筛选晚期胃癌患者中EGFR,HER2和MET的新平台
Division of Hematology-Oncology Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine">(1);
Gastric Cancer Center Samsung Medical Center Sungkyunkwan University School of Medicine">(2);
Department of Pathology and Translational Genomics Samsung Medical Center Sungkyunkwan University School of Medicine">(3);
Department of Pathology Center for Companion Diagnostics The Innovative Cancer Medicine Institute Samsung Medical Center Sungkyunkwan University School of Medicine">(4);
Division of Hematology-Oncology Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine">(1);
Gastric Cancer Center Samsung Medical Center Sungkyunkwan University School of Medicine">(2);
Samsung Cancer Research Institute">(5);
Department of Pathology and Translational Genomics Samsung Medical Center Sungkyunkwan University School of Medicine">(3);
Department of Pathology Center for Companion Diagnostics The Innovative Cancer Medicine Institute Samsung Medical Center Sungkyunkwan University School of Medicine">(4);
Division of Hematology-Oncology Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine">(1);
Gastric Cancer Center Samsung Medical Center Sungkyunkwan University School of Medicine">(2);
Epidermal growth factor receptor (EGFR); Human epidermal growth factor 2 (HER2); N-Methyl-N-nitrosoguanidine human osteosarcoma transforming gene (MET); NanoString; Immunohistochemistry; Gastric cancer;
机译:基于NanoString的多基因检测作为筛选晚期胃癌患者EGFR,HER2和MET的新平台
机译:通过基于纳米串的多基因分析挖掘卡培他滨加RAD001反应的生物标志物,以预测晚期胃癌患者的反应
机译:晚期胃癌患者肝转移中HER2的优先表达和腹膜转移中的EGFR表达
机译:NCounter CNV测定检测HER2扩增:在220个晚期胃癌组织队列中的免疫组织化学和荧光的相关性研究
机译:导致晚期非小细胞肺癌患者营养风险的症状:在晚期肺癌人群中进行营养筛查的重要性
机译:通过基于纳米串的多基因分析挖掘卡培他滨加RAD001的反应的生物标志物预测晚期胃癌患者的反应。
机译:挖掘在晚期胃癌患者中通过基于纳米体的多硫代肾上腺素测定来预测Capecitabine Plus Rad001的响应的生物标志物